"Last week, the American Academy of Pediatrics (AAP) rejected SEGM’s application to share the latest evidence regarding the practice of pediatric gender transition at AAP's upcoming annual conference in Philadelphia in October 2021. /1
segm.org/AAP_silences_d… via @SEGMtweets
segm.org/AAP_silences_d… via @SEGMtweets
"This rejection sends a strong signal that the AAP does not want to see any debate on what constitutes evidence-based care for gender-diverse youth. /2
"The risks of "gender-affirmative" hormones and surgeries include not only the immediate adverse effects of these interventions, /3
"but also the lasting negative effects on bone, cardiovascular health, and fertility, as well as unknown effects of life-long cross-sex hormonal supplementation. /4
"There is also a growing risk of misdiagnosing and wrongly treating young people whose gender dysphoria is a temporary phase of their identity formation /5
"It is not yet known how many of the young people treated today will regret their medical transition, /6
"but there is already evidence of a growing number of young detransitioners: youth who underwent gender reassignment as their teens and young adult years, and who have since come to regret their gender transition and no longer identify as transgender. /7
We urgently need respectful, fact-based discussions of these matters throughout US society. /8
• • •
Missing some Tweet in this thread? You can try to
force a refresh
